In a post on Truth Social, US President Trump said additional 10% import tariffs would take effect on February 1, 2026 on goods from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland and Great Britain. Those tariffs would increase to 25% on June 1, 2026 and would continue until a deal was reached for the US to purchase Greenland, Trump wrote.

The pharmaceutical industry will, just like other industries in the Nordics, be affected if the new tariffs come into effect.

Related article

New Trump campaign on tariffs shows that the EU’s internal market must be strengthened, states SwedenBIO

President Trump recently announced that trademarked or patented pharmaceutical products will be subject to a 100 percent tariff starting October 1, 2025 – unless the manufacturer establishes a production facility in the United States. The latest move reinforces the uncertainty that the life sciences industry is already experiencing and raises a number of questions about […]
Related article

US life sciences under Trump

While reports of federal cutbacks across the US health, life sciences, and research landscapes continue to fuel anxiety among scientists, the situation may not be as dire as people fear, according to one investor.